Cargando…

More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC

In patients with cirrhosis, particularly those with hepatocellular carcinoma (HCC), hypercoagulability may be associated with purported increased risks of portal vein thrombosis and cirrhosis progression. In this study, we extensively investigated hemostatic alterations potentially responsible for t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zanetto, Alberto, Campello, Elena, Bulato, Cristiana, Gavasso, Sabrina, Saggiorato, Graziella, Shalaby, Sarah, Spiezia, Luca, Cillo, Umberto, Farinati, Fabio, Russo, Francesco Paolo, Burra, Patrizia, Senzolo, Marco, Simioni, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631093/ https://www.ncbi.nlm.nih.gov/pubmed/34558850 http://dx.doi.org/10.1002/hep4.1781

Ejemplares similares

Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections
por: Zanetto, Alberto, et al.
Publicado: (2022)

Influence of Hepatocellular Carcinoma on Platelet Aggregation in Cirrhosis
por: Zanetto, Alberto, et al.
Publicado: (2021)

Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study
por: Campello, Elena, et al.
Publicado: (2021)

Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute‐on‐chronic liver failure
por: Campello, Elena, et al.
Publicado: (2021)

Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study
por: Campello, Elena, et al.
Publicado: (2022)

Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study
por: Ferrarese, Alberto, et al.
Publicado: (2018)

Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma
por: Zanetto, Alberto, et al.
Publicado: (2018)

Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19
por: Campello, Elena, et al.
Publicado: (2022)

Development and application of global assays of hyper‐ and hypofibrinolysis
por: Ilich, Anton, et al.
Publicado: (2019)

Toward a more precise prognostic stratification in acute decompensation of cirrhosis: The Padua model 2.0
por: Zanetto, Alberto, et al.
Publicado: (2023)

Acute pulmonary embolism in COVID-19 related hypercoagulability
por: Lorenzo, Cerruti, et al.
Publicado: (2020)

Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019
por: Wada, Hideo, et al.
Publicado: (2023)

Correction to: Acute pulmonary embolism in COVID-19 related hypercoagulability
por: Cerruti, Lorenzo, et al.
Publicado: (2020)

Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study
por: Campello, Elena, et al.
Publicado: (2020)

Reduced Clot Stability by Thromboelastography as a Potential Indicator of Procedure‐Related Bleeding in Decompensated Cirrhosis
por: Zanetto, Alberto, et al.
Publicado: (2020)

Recent Advances in the Management of Acute Variceal Hemorrhage
por: Zanetto, Alberto, et al.
Publicado: (2021)

Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites
por: Ferrarese, Alberto, et al.
Publicado: (2018)

New Indications for Liver Transplantation
por: Zanetto, Alberto, et al.
Publicado: (2021)

The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues
por: Campello, Elena, et al.
Publicado: (2019)

More Severe Hypercoagulable State in Acute COVID-19 Pneumonia as Compared With Other Pneumonia
por: Spiezia, Luca, et al.
Publicado: (2020)

WITHDRAWN: More Severe Hypercoagulable State in Acute COVID-19 Pneumonia as Compared to Other Oneumonia
por: Spiezia, Luca, et al.
Publicado: (2021)

Management of bacterial infection in the liver transplant candidate
por: Ferrarese, Alberto, et al.
Publicado: (2018)

The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation
por: Battistella, Sara, et al.
Publicado: (2023)

Serial EXTEM, FIBTEM, and tPA Rotational Thromboelastometry Observations in the Maastricht Intensive Care COVID Cohort—Persistence of Hypercoagulability and Hypofibrinolysis Despite Anticoagulation
por: Hulshof, Anne-Marije, et al.
Publicado: (2021)

Therapeutic approaches for portal biliopathy: A systematic review
por: Franceschet, Irene, et al.
Publicado: (2016)

Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?
por: Russo, Francesco Paolo, et al.
Publicado: (2022)

Hypercoagulability State Combined with Post-Treatment Hypofibrinolysis in Invasive Breast Cancer: A Seven-Year Follow-Up Evaluating Disease-Free and Overall Survival
por: Wrzeszcz, Katarzyna, et al.
Publicado: (2023)

OC.04.8 IMPACT OF COVID-19 PANDEMIC ON REFERRAL OF PATIENTS WITH LIVER DISEASE TO A LIVER TRANSPLANT CENTER
por: Germani, G., et al.
Publicado: (2021)

Long-Term Impact of Direct-Acting Antivirals on Liver Fibrosis and Survival in HCV-Infected Liver Transplant Recipients
por: Gambato, Martina, et al.
Publicado: (2023)

Determinants of hypofibrinolysis in patients with digestive tract cancer
por: Gronostaj, Katarzyna, et al.
Publicado: (2016)

Mixed Fibrinolytic Phenotypes in Decompensated Cirrhosis and Acute‐on‐Chronic Liver Failure with Hypofibrinolysis in Those With Complications and Poor Survival
por: Blasi, Annabel, et al.
Publicado: (2019)

The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study
por: Tormene, Daniela, et al.
Publicado: (2021)

Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
por: Battistella, Sara, et al.
Publicado: (2023)

Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation
por: Pelizzaro, Filippo, et al.
Publicado: (2021)

Progression of liver cirrhosis to HCC: an application of hidden Markov model
por: Bartolomeo, Nicola, et al.
Publicado: (2011)

Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk
por: Kearney, Katherine, et al.
Publicado: (2017)

Plasma Fibrinogen Independently Predicts Hypofibrinolysis in Severe COVID-19
por: Schrick, Diana, et al.
Publicado: (2021)

Invasive fungal infection before and after liver transplantation
por: Ferrarese, Alberto, et al.
Publicado: (2020)

Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy
por: Ferrarese, Alberto, et al.
Publicado: (2022)

COVID-19 and liver disease: where are we now?
por: Russo, Francesco Paolo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_clpcdfuhij5nm3lv9rshkfloe9